AOD-9604Q, a synthetic fragment of human growth hormone (hGH), has emerged as a potential therapeutic candidate for addressing various musculoskeletal disorders. here Its targeted mechanism of action involves interacting with the growth hormone receptor, primarily stimulating collagen synthesis and promoting bone density. Preclinical studies have